Life Science Solutions

Human Fetal Lung Fibroblast Cells (MRC-5 Line)

Human Fetal Lung Fibroblast Cells (MRC-5 Line)

The MRC-5 cell line is commonly utilized in vaccine development, as a transfection host in virology research, and for in vitro cytotoxicity testing. Initiated in September 1966 by J. P. Jacobs, the cell line was derived from the human lung tissue of a 14-week-old male fetus aborted from a 27-year-old woman.

Sorry, this page is not
available in your country.